Carmustine and Enterocolitis - a phase IV clinical study of FDA data

Summary:

Enterocolitis is reported as a side effect among people who take Carmustine (carmustine), especially for people who are male, 40-49 old, also take Cytarabine, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Enterocolitis when taking Carmustine. It is created by eHealthMe based on reports of 4,562 people who have side effects when taking Carmustine from the FDA, and is updated regularly.

What is Carmustine?

Carmustine has active ingredients of carmustine. eHealthMe is studying from 4,562 Carmustine users. Check the latest studies of Carmustine.

What is Enterocolitis?

Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon) is found to be associated with 711 drugs and 728 conditions by eHealthMe. Check the latest studies of Enterocolitis.

On Jan, 15, 2026

4,562 people reported to have side effects when taking Carmustine.
Among them, 23 people (0.5%) have Enterocolitis.

Among these 23 people:

What is the gender of people who have Enterocolitis when taking Carmustine? *

female: 5.56 %
male: 94.44 %

What is the age of people who have Enterocolitis when taking Carmustine? *

What are other drugs people take besides Carmustine? *

What are other side effects people have besides Enterocolitis? *

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 17 people, 73.91%
Neuropathy Peripheral (surface nerve damage): 14 people, 60.87%
Pneumonia: 8 people, 34.78%
Atypical Pneumonia (acute respiratory disease marked by high fever and coughing): 6 people, 26.09%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 4 people, 17.39%
Infection: 3 people, 13.04%
Embolism Venous (embolus may pass into the arterial system): 3 people, 13.04%
Thrombocytopenia (decrease of platelets in blood): 3 people, 13.04%
Wound Infection: 3 people, 13.04%
Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 3 people, 13.04%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 14 people, 60.87%
Burkitt Lymphoma (cancer of the lymphatic system): 5 people, 21.74%
Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 2 people, 8.70%
Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Carmustine and have Enterocolitis?

- Check whether Enterocolitis is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carmustine:

Carmustine (4,562 reports)

Enterocolitis treatments and more:

Enterocolitis (7,684 reports)

Browse all side effects of Carmustine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Enterocolitis:

Enterocolitis (711 drugs)

Browse all the conditions that are associated with Enterocolitis:

Enterocolitis (728 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on carmustine (the active ingredients of Carmustine) and Carmustine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.